Disseminated Carcinoma Ex Pleomorphic Adenoma in an Adolescent Confirmed by Application of PLAG1 Immunohistochemistry and FISH for PLAG1 Rearrangement

Head and Neck Pathology

Volumn 6, Issue 3, 2012, Pages 377-383

  Bahrami, Armita ^a   Dalton, James D ^a   Bangalore, Shivakumar ^a   Henry, Charlene ^a   Krane, Jeffrey F ^b   Navid, Fariba ^a   Ellison, David W ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Carcinoma ex pleomorphic adenoma; Carcinoma of unknown primary; PLAG1; Salivary gland

Indexed keywords

DNA BINDING PROTEIN; PLAG1 PROTEIN, HUMAN;

ADOLESCENT; ARTICLE; BONE TUMOR; CARCINOMA; CASE REPORT; CELL TRANSFORMATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE REARRANGEMENT; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG TUMOR; MEDIASTINUM TUMOR; METASTASIS; PAROTID GLAND TUMOR; PATHOLOGY; PLEOMORPHIC ADENOMA;

ADENOMA, PLEOMORPHIC; ADOLESCENT; BONE NEOPLASMS; CARCINOMA; CELL TRANSFORMATION, NEOPLASTIC; DNA-BINDING PROTEINS; FEMALE; GENE AMPLIFICATION; GENE REARRANGEMENT; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; LUNG NEOPLASMS; MEDIASTINAL NEOPLASMS; PAROTID NEOPLASMS;

EID: 84865546354     PISSN: 1936055X     EISSN: 19360568     Source Type: Journal    
DOI: 10.1007/s12105-012-0330-2     Document Type: Article

References (33)

1. Gnepp DR. Malignant mixed tumors of the salivary glands: a review. Pathol Annu. 1993; 28(Pt 1): 279-328.
2. Gnepp DR, Brandwein M, El-Naggar AK, et al. Pleomorphic adenoma. In: Barnes L, Eveson JW, Reichart P, Sidransky D, editors. World health organization classification of tumours. Pathology and genetics of head and neck tumours. IARC Press: France; 2005. pp. 242-244.
3. Olsen KD, Lewis JE. Carcinoma ex pleomorphic adenoma: a clinicopathologic review. Head Neck. 2001; 23: 705-12.
4. Greco FA, Hainsworth JD. Introduction: unknown primary cancer. Semin Oncol. 2009; 36: 6-7.
5. Bourke JL, Langer SW, Jensen HL. Metastasizing malignant pleomorphic adenoma in a young man. APMIS. 2007; 115: 866-8.
6. Ellison DW, Kocak M, Dalton J, et al. Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables. J Clin Oncol. 2011; 29: 1400-7.
7. Athale UH, Shurtleff SA, Jenkins JJ, et al. Use of reverse transcriptase polymerase chain reaction for diagnosis and staging of alveolar rhabdomyosarcoma, Ewing sarcoma family of tumors, and desmoplastic small round cell tumor. J Pediatr Hematol Oncol. 2001; 23: 99-104.
8. Auclair PL, Ellis GL. Atypical features in salivary gland mixed tumors: their relationship to malignant transformation. Mod Pathol. 1996; 9: 652-7.
9. Lewis JE, Olsen KD, Sebo TJ. Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 cases. Hum Pathol. 2001; 32: 596-604.
10. Miller RE, Illing RO, Whelan JS. Lung carcinoma with hypertrophic osteoarthropathy in a teenager. Rare Tumors. 2011; 3: e8.
11. Tortoledo ME, Luna MA, Batsakis JG. Carcinomas ex pleomorphic adenoma and malignant mixed tumors. Histomorphologic indexes. Arch Otolaryngol. 1984; 110: 172-6.
12. Brandwein M, Huvos AG, Dardick I, et al. Noninvasive and minimally invasive carcinoma ex mixed tumor: a clinicopathologic and ploidy study of 12 patients with major salivary tumors of low (or no?) malignant potential. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996; 81: 655-64.
13. Felix A, Rosa-Santos J, Mendonca ME, et al. Intracapsular carcinoma ex pleomorphic adenoma. Report of a case with unusual metastatic behaviour. Oral Oncol. 2002; 38: 107-10.
14. Katabi N, Gomez D, Klimstra DS, et al. Prognostic factors of recurrence in salivary carcinoma ex pleomorphic adenoma, with emphasis on the carcinoma histologic subtype: a clinicopathologic study of 43 cases. Hum Pathol. 2010; 41: 927-34.
15. Bullerdiek J, Wobst G, Meyer-Bolte K, et al. Cytogenetic subtyping of 220 salivary gland pleomorphic adenomas: correlation to occurrence, histological subtype, and in vitro cellular behavior. Cancer Genet Cytogenet. 1993; 65: 27-31.
16. Mark J, Dahlenfors R. Cytogenetical observations in 100 human benign pleomorphic adenomas: specificity of the chromosomal aberrations and their relationship to sites of localized oncogenes. Anticancer Res. 1986; 6: 299-308.
17. Mark J, Sandros J, Wedell B, et al. Significance of the choice of tissue culture technique on the chromosomal patterns in human mixed salivary gland tumors. Cancer Genet Cytogenet. 1988; 33: 229-44.
18. Sandros J, Stenman G, Mark J. Cytogenetic and molecular observations in human and experimental salivary gland tumors. Cancer Genet Cytogenet. 1990; 44: 153-67.
19. Kas K, Voz ML, Roijer E, et al. Promoter swapping between the genes for a novel zinc finger protein and beta-catenin in pleiomorphic adenomas with t(3; 8)(p21; q12) translocations. Nat Genet. 1997; 15: 170-4.
20. Kas K, Roijer E, Voz M, et al. A 2-Mb YAC contig and physical map covering the chromosome 8q12 breakpoint cluster region in pleomorphic adenomas of the salivary glands. Genomics. 1997; 43: 349-58.
21. Geurts JM, Schoenmakers EF, Roijer E, et al. Expression of reciprocal hybrid transcripts of HMGIC and FHIT in a pleomorphic adenoma of the parotid gland. Cancer Res. 1997; 57: 13-7.
22. Geurts JM, Schoenmakers EF, Roijer E, et al. Identification of NFIB as recurrent translocation partner gene of HMGIC in pleomorphic adenomas. Oncogene. 1998; 16: 865-72.
23. Stenman G. Fusion oncogenes and tumor type specificity-insights from salivary gland tumors. Semin Cancer Biol. 2005; 15: 224-35.
24. Astrom AK, Voz ML, Kas K, et al. Conserved mechanism of PLAG1 activation in salivary gland tumors with and without chromosome 8q12 abnormalities: identification of SII as a new fusion partner gene. Cancer Res. 1999; 59: 918-23.
25. Matsuyama A, Hisaoka M, Nagao Y, et al. Aberrant PLAG1 expression in pleomorphic adenomas of the salivary gland: a molecular genetic and immunohistochemical study. Virchows Arch. 2011.
26. Martins C, Fonseca I, Roque L, et al. PLAG1 gene alterations in salivary gland pleomorphic adenoma and carcinoma ex-pleomorphic adenoma: a combined study using chromosome banding, in situ hybridization and immunocytochemistry. Mod Pathol. 2005; 18: 1048-55.
27. Voz ML, van de Ven WJ, Kas K. First insights into the molecular basis of pleomorphic adenomas of the salivary glands. Adv Dent Res. 2000; 14: 81-3.
28. Kas K, Voz ML, Hensen K, et al. Transcriptional activation capacity of the novel PLAG family of zinc finger proteins. J Biol Chem. 1998; 273: 23026-32.
29. Voz ML, Agten NS, van de Ven WJ, et al. PLAG1, the main translocation target in pleomorphic adenoma of the salivary glands, is a positive regulator of IGF-II. Cancer Res. 2000; 60: 106-13.
30. Voz ML, Mathys J, Hensen K, et al. Microarray screening for target genes of the proto-oncogene PLAG1. Oncogene. 2004; 23: 179-91.
31. Hibbard MK, Kozakewich HP, Dal CP, et al. PLAG1 fusion oncogenes in lipoblastoma. Cancer Res. 2000; 60: 4869-72.
32. Landrette SF, Kuo YH, Hensen K, et al. Plag1 and Plagl2 are oncogenes that induce acute myeloid leukemia in cooperation with Cbfb-MYH11. Blood. 2005; 105: 2900-7.
33. Zatkova A, Rouillard JM, Hartmann W, et al. Amplification and overexpression of the IGF2 regulator PLAG1 in hepatoblastoma. Genes chromosomes. Cancer. 2004; 39: 126-37.